Summary of Significant Accounting Policies (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
| Accounting Policies [Abstract] |
|
| Schedule of Accounts Receivable |
The
following is a summary of the Company’s accounts receivable at December 31, 2025 and 2024:
Schedule of Accounts Receivable
| | |
December
31,
2025 | | |
December
31,
2024 | |
| Accounts receivable | |
$ | 2,108,395 | | |
$ | 1,696,436 | |
| Less: allowance for
doubtful accounts | |
| 69,181 | | |
| 81,772 | |
| Accounts receivable
– net | |
$ | 2,039,214 | | |
$ | 1,614,664 | |
|
| Schedule of Bad Debt |
For
the years ended December 31, 2025 and 2024, bad debt was as follows:
Schedule
of Bad Debt
| | |
December
31,
2025 | | |
December
31,
2024 | |
| Bad debt expense | |
$ | 5,654 | | |
$ | 41,836 | |
|
| Schedule of Concentration of Risk |
The
following table presents customers and vendors that individually accounted for more than 10% of total sales, accounts receivable, or
vendor purchases in the comparative periods presented:
Schedule of Concentration of Risk
Sales
| | |
Year
Ended December 31, | |
| Customer | |
2025 | | |
2024 | |
| A | |
| 6.43 | % | |
| 20.19 | % |
| B | |
| 3.10 | % | |
| 9.72 | % |
| C | |
| 52.16 | % | |
| - | % |
| Total | |
| 29.91 | % | |
| 29.91 | % |
Accounts Receivable
| | |
Year
Ended December 31, | | |
Year
Ended December 31, | |
| Customer | |
2025 | | |
2024 | |
| A | |
| 22.42 | % | |
| 37.56 | % |
| B | |
| 4.22 | % | |
| 8.54 | % |
| C | |
| 20.17 | % | |
| - | % |
| D | |
| 10.73 | % | |
| 5.59 | % |
| Total | |
| 46.10 | % | |
| 46.10 | % |
Vendor Purchases
| | |
Year
Ended December 31, | |
| Vendor | |
2025 | | |
2024 | |
| A | |
| 19.37 | % | |
| 40.48 | % |
| B | |
| 11.02 | % | |
| 34.43 | % |
| C | |
| 4.74 | % | |
| 13.69 | % |
| D | |
| 59.89 | % | |
| 1 | % |
| Total | |
| 98.60 | % | |
| 98.60 | % |
|
| Schedule of Disaggregation of Revenue |
The
following represents the Company’s disaggregation of revenues for the years ended December 31, 2025 and 2024:
Schedule of Disaggregation of Revenue
| | |
Year Ended December 31, | |
| | |
2025 | | |
2024 | |
| | |
Revenue | | |
% of Revenues | | |
Revenue | | |
% of Revenues | |
| | |
| | |
| | |
| | |
| |
| Fuel sales | |
$ | 79,001,833 | | |
| 96.54 | % | |
$ | 26,694,186 | | |
| 96.13 | % |
| Other | |
| 2,833,446 | | |
| 3.46 | % | |
| 1,076,093 | | |
| 3.87 | % |
| Total Sales | |
$ | 81,835,279 | | |
| 100.00 | % | |
$ | 27,770,279 | | |
| 100.00 | % |
|
| Schedule of Dilutive Equity Securities Outstanding |
The
following potentially dilutive equity securities outstanding as of December 31, 2025 and 2024 were as follows:
Schedule of Dilutive Equity Securities Outstanding
| | |
December 31, 2025 | | |
December 31, 2024 | |
| Series A, preferred stock | |
| 61,810 | | |
| 1,644,022 | |
| Series B, preferred stock | |
| 724,638 | | |
| 724,638 | |
| Series A, preferred stock - dividends | |
| 31,706 | | |
| 61,204 | |
| Series B, preferred stock - dividends | |
| 21,739 | | |
| 32,372 | |
| Warrants (vested) | |
| 2,735,895 | | |
| 46,344 | |
| Total common stock equivalents | |
| 3,575,788 | | |
| 2,508,580 | |
|